Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Pharming Group N.V (PHAR) FCF Margin: 2020-2022

Historic FCF Margin for Pharming Group N.V (PHAR) over the last 2 years, with Dec 2022 value amounting to 1.50%.

  • Pharming Group N.V's FCF Margin fell 304.00% to 1.50% in Q4 2022 from the same period last year, while for Dec 2022 it was 0.41%, marking a year-over-year decrease of 414.00%. This contributed to the annual value of -0.27% for FY2024, which is 32.00% up from last year.
  • As of Q4 2022, Pharming Group N.V's FCF Margin stood at 1.50%, which was up 115.26% from -9.80% recorded in Q3 2022.
  • In the past 5 years, Pharming Group N.V's FCF Margin registered a high of 32.48% during Q3 2020, and its lowest value of -9.80% during Q3 2022.
  • Its 3-year average for FCF Margin is 13.21%, with a median of 14.85% in 2021.
  • Data for Pharming Group N.V's FCF Margin shows a maximum YoY crashed of 3,325bps (in 2022) over the last 5 years.
  • Pharming Group N.V's FCF Margin (Quarterly) stood at 25.06% in 2020, then tumbled by 2,052bps to 4.54% in 2021, then plummeted by 304bps to 1.50% in 2022.
  • Its FCF Margin was 1.50% in Q4 2022, compared to -9.80% in Q3 2022 and 9.01% in Q2 2022.